A groundbreaking clause in a deal between the Department of Health and Human Ser...
Menarini Asia-Pacific has entered a long-term exclusive agreement to license Ast...
Dewpoint Therapeutics entered a collaboration with Chemify to expedite the disco...
The company will divest the AVTX-800 rare disease compound series to AUG Therape...
Currently, NSCLC patients with EGFR exon 19 deletions or L858R substitution face...
On August 28, the FDA approved the label expansion of Bristol Myers Squibb’s Reb...
The FDA is also reviewing a subcutaneous formulation of Takeda’s blockbuster dru...
The US Food and Drug Administration has sent letters to eight companies for unau...
The patch allows for vaccine storage and transport at room temperature along wit...
Diet and weight-loss drugs have entered the public consciousness, particularly f...
Roche planned to launch its new subcutaneous Tecentriq formulation this year, bu...
A CDC analysis suggested that a universal recommendation for updated Covid vacci...
Food companies are pleading with regulators not to focus their attention on ultr...
The White House outlined its efforts to end shortages of three key generic chemo...
Neurocrine Biosciences announced on Tuesday that an experimental drug for congen...
The leading decongestant used by millions of Americans looking for relief from a...
